The help of PEMF therapy for Parkinson’s Disease

cite this

Elaine Diamond (2021, October 14). Helping PEMF treatment for Parkinson’s disease. Psychreg on Cognitive Psychology. https://www.psychreg.org/help-pemf-therapy-parkinsons-disease/

reading time: 3 Minutes

Parkinson’s disease is one of the most common neurodegenerative disorders worldwide. It is the second most common disease after Alzheimer’s disease. Since it is neurodegeneration, this means that cells in a certain part of the brain continue to die in this condition. It is an irreversible loss of brain cells. Thus, medical treatment focuses on slowing its progression and improving the quality of life for those living with the condition.

Statistics show that about 60,000 people are diagnosed with Parkinson’s disease alone each year in the United States. It is estimated that there are more than 10 million people living with it globally. It is a condition that appears to be more common in men than in women.

It is a chronic condition and progresses slowly. This means that it does not cause death in a short time, although it does reduce the life span. Instead, it causes years of disability and a burden on health care.

Most people know that Parkinson’s disease is related to involuntary tremors and rigidity and thus the inability to function properly. However, most people don’t realize that as the disease progresses, it affects other brain functions as well. Therefore, it causes a decrease in cognition, memory, sleep quality, sexual function, mood, and much more.

Researchers know what happens in Parkinson’s disease, although they don’t understand why it occurs. In this case, dopamine-producing cells die in specific brain centers, especially in the substantia nigra.

Researchers know that it has something to do with genetics. But environmental factors seem to play a more important role. There is a family history of the disease in only about 10% of all people with this condition. It is most likely caused by some toxins, pollutants, or even brain trauma. These toxins or trauma often cause mitochondrial dysfunction and cell death.

Experts also know that the disease is caused by a lack of dopamine in certain parts of the brain. This is because the substantia nigra produces dopamine. Therefore, most current treatments focus on increasing dopamine production in the brain or improving quality of life. But there is no known treatment that may help prevent further brain cell death, boost the metabolic activity of brain cells, and prevent mitochondrial dysfunction. Thus, there is a need to test treatments such as PEMF.

Levodopa is generally considered the first-line treatment for the condition. But there are many problems with this treatment. Dopamine is released in the brain as needed. However, levodopa provides consistently high amounts of dopamine. Thus, it may help well during certain times and may fail at other times. Further, the disease progresses, and slowly the body gets used to levodopa and stops responding.

From previous studies, researchers know that PEMF may affect the brain, prevent brain cell death, and help normalize mitochondrial dysfunction. As a result, it has been approved for use in some cases of resistant depression. Early studies also show that it is well suited for managing depression associated with Parkinson’s disease.

There are many other reasons to believe that PEMF can be an excellent alternative or additional treatment for Parkinson’s disease. In Parkinson’s disease, motor symptoms such as tremors or rigidity are just one of the signs. It also causes many other problems. PEMF is a broad procedure and yet a very safe treatment. Moreover, PEMF acts on the brain and also helps to improve the healing processes in the body.

There are several early studies confirming the benefits of PEMF in Parkinson’s disease. It may not only help improve motor cues but may have more comprehensive benefits for health. PEMF may also help with mood swings, boost sexual health, improve sleep quality, and prevent cognitive decline.

One can find many PEMF mats for managing Parkinson’s disease at healthlineoutlet.


Elaine Diamond received her degree in Psychology from the University of Edinburgh. She has an ongoing interest in mental health and well-being.


Disclaimer: Psychreg is mainly for information purposes only. The materials on this site are not intended as a substitute for professional advice, diagnosis, medical treatment or treatment. Never disregard professional psychological or medical advice and do not delay seeking professional advice or treatment because of something you have read on this site. Read the full disclaimer here.

Leave a Comment